156 related articles for article (PubMed ID: 38521544)
21. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
22. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
23. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
[TBL] [Abstract][Full Text] [Related]
24. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
[TBL] [Abstract][Full Text] [Related]
25. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
Tran C; Cipriano LE; Driman DK
CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
[TBL] [Abstract][Full Text] [Related]
26. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
27. [Opportunistic cancer screening in primary health care. A person out of 13 has symptoms and three out of 1,000 have a tumor].
Karlsson L; Håkansson A; Nordenskiöld B
Lakartidningen; 2002 Jun; 99(23):2636-8. PubMed ID: 12101617
[No Abstract] [Full Text] [Related]
28. The Odds of Stage IV Melanoma Diagnoses Based on Socioeconomic Factors.
Dick M; Aurit S; Silberstein P
J Cutan Med Surg; 2019; 23(4):421-427. PubMed ID: 31081374
[TBL] [Abstract][Full Text] [Related]
29. Access denied: The relationship between patient insurance status and access to high-volume hospitals.
Nabi J; Tully KH; Cole AP; Marchese M; Cone EB; Melnitchouk N; Kibel AS; Trinh QD
Cancer; 2021 Feb; 127(4):577-585. PubMed ID: 33084023
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
31. The importance of age in screening for cancer.
Law MR; Morris JK; Wald NJ
J Med Screen; 1999; 6(1):16-20. PubMed ID: 10321365
[TBL] [Abstract][Full Text] [Related]
32. Trends in Breast, Colorectal, and Cervical Cancer Incidence Following the Affordable Care Act: Implications for Cancer Screening.
Sun M; Cole AP; Lipsitz SL; Trinh QD
JAMA Oncol; 2018 Jan; 4(1):128-129. PubMed ID: 29098266
[TBL] [Abstract][Full Text] [Related]
33. Changes in Insurance Coverage and Stage at Diagnosis Among Nonelderly Patients With Cancer After the Affordable Care Act.
Jemal A; Lin CC; Davidoff AJ; Han X
J Clin Oncol; 2017 Dec; 35(35):3906-3915. PubMed ID: 28885865
[TBL] [Abstract][Full Text] [Related]
34. Estimates of cancer burden in Lazio.
Rashid I; Pannozzo F; Rossi S; Foschi R
Tumori; 2013; 99(3):359-65. PubMed ID: 24158065
[TBL] [Abstract][Full Text] [Related]
35. Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base.
Coghill AE; Han X; Suneja G; Lin CC; Jemal A; Shiels MS
Cancer; 2019 Aug; 125(16):2868-2876. PubMed ID: 31050361
[TBL] [Abstract][Full Text] [Related]
36. Changes in cancer diagnoses and stage distribution during the first year of the COVID-19 pandemic in the USA: a cross-sectional nationwide assessment.
Han X; Yang NN; Nogueira L; Jiang C; Wagle NS; Zhao J; Shi KS; Fan Q; Schafer E; Yabroff KR; Jemal A
Lancet Oncol; 2023 Aug; 24(8):855-867. PubMed ID: 37541271
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
38. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
39. Estimates of cancer burden in Campania.
Fusco M; De Angelis R; Senatore G; Zigon G; Rossi S
Tumori; 2013; 99(3):374-81. PubMed ID: 24158067
[TBL] [Abstract][Full Text] [Related]
40. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
